Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia: a systematic review.
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
accepted:
13
05
2020
pubmed:
20
5
2020
medline:
5
10
2021
entrez:
20
5
2020
Statut:
ppublish
Résumé
Type 2 diabetes is a growing global challenge. Evidence exists demonstrating the use of primary care (non-hospital based) dental practices to identify, through risk assessments, those who may be at increased risk of type 2 diabetes or who may already unknowingly have the condition. This review aimed to synthesize evidence associated with the use of primary care dental services for the identification of undiagnosed non-diabetic hyperglycaemia or type 2 diabetes in adults, with particular focus on the pick-up rate of new cases. Electronic databases were searched for studies reporting the identification of non-diabetic hyperglycaemia/type 2 diabetes in primary care dental settings. Returned articles were screened and two independent reviewers completed the data-extraction process. A descriptive synthesis of the included articles was undertaken due to the heterogeneity of the literature returned. Nine studies were identified, the majority of which utilized a two-stage risk-assessment process with risk score followed by a point-of-care capillary blood test. The main barriers cited were cost, lack of adequate insurance cover and people having previously been tested elsewhere. The pick-up rate of new cases of type 2 diabetes and non-diabetic hyperglycaemia varied greatly between studies, ranging from 1.7% to 24% for type 2 diabetes and from 23% to 45% for non-diabetic hyperglycaemia, where reported. This review demonstrates that although it appears there may be benefit in using the dental workforce to identify undiagnosed cases of non-diabetic hyperglycaemia and type 2 diabetes, further high-quality research in the field is required assessing both the clinical and cost effectiveness of such practice. (Prospero Registration ID: PROSPERO 2018 CRD42018098750).
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1443-1453Informations de copyright
© 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012; 29: 855-862.
Diabetes UK. Early Identification of People With, and at High Risk of Type 2 Diabetes and Interventions for Those at High Risk; 2015. Available at https://www.diabetes.org.uk/professionals/position-statements-reports/type-2-diabetes-prevention-early-identification Last accessed 21 May 2017.
National Cardiovascular Intelligence Network. NHS Diabetes Prevention Programme (NHS DPP) Non-Diabetic Hyperglycaemia. Public Health England: London, 2015. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/456149/Non_diabetic_hyperglycaemia.pdf Last accessed 12 December 2019.
Yonel Z, Sharma P, Gray LJ. Use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or nondiabetic hyperglycemia: protocol for a systematic review. JMIR Res Protoc 2018; 7: e11843.
Public Health England. NHS Diabetes Prevention Programme (NHS DPP) short report 2018-2019. Public Health England: London, 2019. Online Report. Available at https://www.gov.uk/government/publications/nhs-diabetes-prevention-programme-non-diabetic-hyperglycaemia Last accessed 6 January 2020.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 7346: 393-403.
Hopper I, Billah B, Skiba M, Krum H. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 2011; 18: 813-823.
Ashra NB, Spong R, Carter P, Davies MJ, Dunkley A, Gillies C et al. A Systematic Review and Meta-Analysis Assessing the Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus in Routine Practice. Public Health England: London, 2015. Available at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/733053/PHE_Evidence_Review_of_diabetes_prevention_programmes-_FINAL.pdf Last accessed 26 May 2020.
Waugh NR, Shyangdan D, Taylor-Phillips S, Suri G, Hall B. Screening for type 2 diabetes: a short report for the National Screening Committee. Health Technol Assess 17: 1-90.
Barron E, Clark R, Hewings R, Smith J, Valabhji J. Progress of the Healthier You: NHS diabetes prevention programme: referrals, uptake and participant characteristics. Diabet Med 2018; 35: 513-518.
Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012; 380: 1741-1748.
Kassebaum NJ, Bernabe E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res 2014; 93: 1045-153.
Chapple IL, Genco R. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013; 40(Suppl 14): S106-S112.
Sanz M, Ceriello A, Buysschaert M, Chapple IL, Demmer RT, Graziani F et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and by the International Diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract 2018; 137: 231-241.
The Research, Science and Therapy Committee of The American Academy of Periodontology. Position Paper: diabetes and periodontal diseases. J Periodontol 2000; 71: 664-678.
Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J 2014; 217: 433-437.
D’Aiuto F, Gkranias N, Bhowruth D, Khan T, Orlandi M, Suvan J et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol 2018; 6: 954-965.
Estrich C, Araujo MWB, Lipman R. Prediabetes and diabetes screening in dental care settings: NHANES 2013 to 2016. JDR Clin Trans Res 2019; 4: 76-85.
Yonel Z, Sharma P, Yahyouche A, Jalal Z, Dietrich T, Chapple IL. Patients’ attendance patterns to different healthcare settings and perceptions of stakeholders regarding screening for chronic, non-communicable diseases in high street dental practices and community pharmacy: a cross-sectional study. BMJ Open 2018; 8: e024503.
White DA, Tsakos G, Pitts NB, Fuller E, Douglas GVA, Murray JJ et al. Adult Dental Health Survey 2009: common oral health conditions and their impact on the population. Br Dent J 2012; 213: 567-572.
National Instititute for Health and Care Excellence. Type 2 Diabetes: Prevention in People at High Risk, 2017. Public Health Guidance 38. Available at https://www.nice.org.uk/guidance/ph38/chapter/recommendations#recommendation-3-risk-identification-stage-1 Last accessed X X 201X.
Genco RJ, Schifferle RE, Dunford RG, Falkner KL, Hsu WC, Balukjian J. Screening for diabetes mellitus in dental practices: a field trial. J Am Dent Assoc 2014; 145: 57-64.
Lalla E, Cheng B, Kunzel C, Burkett S, Ferraro A, Lamster IB. Six-month outcomes in dental patients identified with hyperglycaemia: a randomized clinical trial. J Clin Periodontol 2015; 42: 228-235.
Lalla E, Cheng B, Kunzel C, Burkett S, Lamster IB. Dental findings and identification of undiagnosed hyperglycemia. J Dent Res 2013; 92: 888-892.
Engstrom S, Berne C, Gahnberg L, Svardsudd K. Effectiveness of screening for diabetes mellitus in dental health care. Diabet Med 2013; 30: 239-245.
Herman WH, Taylor GW, Jacobson JJ, Burke R, Brown MB. Screening for prediabetes and type 2 diabetes in dental offices. J Public Health Dent 2015; 75: 175-182.
Barasch A, Gilbert GH, Spurlock N, Funkhouser E, Persson LL, Safford MM et al. Random plasma glucose values measured in community dental practices: findings from the Dental Practice-Based Research Network. Clin Oral Investig 2013; 17: 1383-1388.
Yonel Z, Batt J, Jane R, Cerullo E, Gray LJ, Dietrich T et al. The role of the oral healthcare team in identification of type 2 diabetes mellitus: a systematic review. Curr Oral Health Rep 2020; 7: 87-97.
Taylor G. Modernising NHS dentistry implementing the plan. Community Dent Health 2000; 17: 207-209.
Department of Health. NHS Dentistry: Options For Change. London: The Stationery Office, 2002. Available at https://publications.parliament.uk/pa/cm200708/cmselect/cmhealth/289/28905.htm#n41 Last accessed 19 December 2019.
Roland M. The Future of Primary Care: Creating Teams for Tomorrow. Leeds: Health Education England, 2015. Available at https://www.hee.nhs.uk/our-work/primary-care-workforce-commission Last accessed 11 February 2020.
Public Health England. Making Every Contact Count. London: NHS England, 2016. Available at https://www.gov.uk/government/publications/making-every-contact-count-mecc-practical-resources Last accessed 11 February 2020.
Yonel Z, Sharma P, Gray LJ. The use of dental practices for the identification of adults with undiagnosed type 2 diabetes mellitus or non-diabetic hyperglycaemia (prediabetes); a systematic review. PROSPERO 2018 CRD42018098750 Available at https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018098750 Last accessed 15 March 2019.
Study Quality Assessment Tools. Available at https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools Last accessed 6 September 2018.
Bould K, Scott SE, Dunne S, Asimakopoulou K. Uptake of screening for type 2 diabetes risk in general dental practice; an exploratory study. Br Dent J 2017; 222: 293-296.
Harase T, Nishida W, Hamakawa T, Hino S, Shigematsu K, Kobayashi S et al. Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study. BMJ Open Diabetes Res Care 2015; 3: e000151.
Bossart M, Calley KH, Gurenlian JR, Mason B, Ferguson RE, Peterson T. A pilot study of an HbA1c chairside screening protocol for diabetes in patients with chronic periodontitis: the dental hygienist's role. Int J Dent Hyg 2016; 14: 98-107.
Ziebolz D, Bauwe I, Schmidt J, Kottmann T, Rinke S, Schmalz G. Diabetes screening in dental practice using the Find-Risk questionnaire - a practice-based pilot study. Oral Health Prev Dent 2019; 17: 147-156.
Mirza W, Saleem MS, Patel G, Chacko P, Reddy S, Schaefer R et al. Early Screening strategies for diabetes mellitus by leveraging dental visits using optimal screening tools available onsite. Cureus 2018; 10: e3641.
Esmeili T, Ellison J, Walsh MM. Dentists’ attitudes and practices related to diabetes in the dental setting. J Public Health Dent 2010; 70: 108-114.
Greenberg BL, Kantor ML, Bednarsh H. American dental hygienists' attitudes towards chairside medical screening in a dental setting. Int J Dent Hyg 2017; 15: e61-e68.
Greenberg BL, Kantor ML, Jiang SYS, Glick M. Patients' attitudes toward screening for medical conditions in a dental setting. J Public Health Dent 2012; 72: 28-35.
Greenblatt AP, Estrada I, Schrimshaw EW, Metcalf SS, Kunzel C, Northridge ME. Acceptability of chairside screening for racial/ethnic minority older adults: a qualitative study. JDR Clin Trans Res 2017; 2: 343-352.
Creanor S, Millward BA, Demaine A, Price L, Smith W, Brown N et al. Patients' attitudes towards screening for diabetes and other medical conditions in the dental setting. Br Dent J 2014; 216: E2.
Scambler S, Asimakopoulou K. Summary of: Patients' attitudes towards screening for diabetes and other medical conditions in the dental setting. Br Dent J 2014; 216: 34-35.
Neidell M, Lamster IB, Shearer B. Cost-effectiveness of diabetes screening initiated through a dental visit. Community Dent Oral Epidemiol 2017; 45: 275-80.
Royle PRL, Andrew M, Waugh N. Updating the Scottish Needs Assessment Programme Report on Type 2 Diabetes: Screening and Prevention Part B: Research review for Scottish Public Health Network - Screening for and Prevention of Type 2 Diabetes. Available at https://www.scotphn.net/projects/type-2-diabetes-needs-assessment-2/type-2-diabetes-needs-assessment/ Last accessed 17 December 2019.
Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K et al. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation. BMJ Open 2018; 8: e019467.
Roberts S, Barry E, Craig D, Airoldi M, Bevan G, Greenhalgh T. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open 2017; 7: e017184.
Bray GA, Culbert IW, Champagne CM, Dawson L, Eberhardt B, Greenway FL et al. The Diabetes Prevention Program - design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999; 22: 623-634.
Strauss SM, Russell S, Wheeler A, Norman R, Borrell LN, Rindskopf D. The dental office visit as a potential opportunity for diabetes screening: an analysis using NHANES 2003-2004 data. J Public Health Dent 2010; 70: 156-162.
Rosedale MT, Strauss SM, Kaur N, Knight C, Malaspina D. Follow-up with primary care providers for elevated glycated haemoglobin identified at the dental visit. Int J Dent Hyg 2017; 15: e52-e60.